Insider · CIK 0001312212

Schouten Jacobus

Reports to the SEC for 1 company · AMSTERDAM, P7

sec.gov

Transactions

Companies

Filings

CIK

0001312212

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-04-01	CORE LABORATORIES N VRestricted SharesA Award	Director	AAward	+1,469 sh	—	—	1,469
2010-08-19	CORE LABORATORIES N VM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	5,920
2010-08-19	CORE LABORATORIES N VF Tax Payment	Director	FTax Payment	−2,080 sh	$78.34	−$163K	3,840
2010-08-19	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2010-04-01	CORE LABORATORIES N VRestricted Performance SharesA Award	Director	AAward	+765 sh	—	—	765
2009-09-15	CORE LABORATORIES N VM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	2,000
2009-09-15	CORE LABORATORIES N VF Tax Payment	Director	FTax Payment	−1,040 sh	$101.96	−$106K	960
2009-09-15	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2009-07-15	CORE LABORATORIES N VRestricted Performance SharesA Award	Director	AAward	+1,157 sh	—	—	1,157
2006-05-01	CORE LABORATORIES N VM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$23.00	+$230K	10,000
2006-05-01	CORE LABORATORIES N VM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$25.00	+$250K	20,000
2006-05-01	CORE LABORATORIES N VS Sale	Director	SSale	−20K sh	$62.80	−$1.26M	0
2006-05-01	CORE LABORATORIES N VOption to Acquire Common SharesM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2006-05-01	CORE LABORATORIES N VOption to Acquire Common SharesM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2005-08-18	CORE LABORATORIES N VM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$12.00	+$24K	2,000
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−200 sh	$29.17	−$5,834	1,800
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−300 sh	$29.20	−$8,760	1,500
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−400 sh	$29.35	−$11.7K	1,100
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−100 sh	$29.42	−$2,942	1,000
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−100 sh	$29.43	−$2,943	900
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−300 sh	$29.44	−$8,832	600
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−100 sh	$29.45	−$2,945	500
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−400 sh	$29.49	−$11.8K	100
2005-08-18	CORE LABORATORIES N VS Sale	Director	SSale	−100 sh	$29.50	−$2,950	0
2005-08-18	CORE LABORATORIES N VOption to Acquire Common SharesM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	$12.00	−$24K	0
2004-12-20	CORE LABORATORIES N VOptioin to acquire Common SharesA Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Apr 44
Schouten Jacobus0001140361-11-020468
SEC(opens sec.gov)
Aug 234
Schouten Jacobus0001140361-10-034668
SEC(opens sec.gov)
Apr 54
Schouten Jacobus0001140361-10-015307
SEC(opens sec.gov)
Sep 254
Schouten Jacobus0001209191-09-045815
SEC(opens sec.gov)
Jul 174
Schouten Jacobus0001209191-09-036977
SEC(opens sec.gov)
May 34
Schouten Jacobus0001209191-06-027519
SEC(opens sec.gov)
Aug 224
CORE LABORATORIES N V0001209191-05-043976
SEC(opens sec.gov)

Companies

CORE LABORATORIES N VDirector

Address

ARONDENSSTRAAT 1

AMSTERDAM, P7, 1063 GB